AbbVie Inc. (ABBV) operating KPIs
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)
Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%
AbbVie gAAP Effective Tax Rate (%) (%)
Form 8-K Non-GAAP Reconciliations & Form 10-K Note 14
Latest, FY2025
35.8%
Period ended Dec 31, 2025
Change on a year earlier
+51.1 pts
-15.3% in FY2024
History
11 years
Since FY2015
Sources
11
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | GAAP Effective Tax Rate (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 35.8% | +51.1 pts | Form 8-K (abbv-20251231xexhibit991.htm, filed 2026-02-04) ↗ |
| FY2024 | Dec 31, 2024 | -15.3% | -37.3 pts | Form 8-K (abbv-20241231xexhibit991.htm, filed 2025-01-31) ↗ |
| FY2023 | Dec 31, 2023 | 22.0% | +9.9 pts | Form 8-K (abbv-20231231xexhibit991.htm, filed 2024-02-02) ↗ |
| FY2022 | Dec 31, 2022 | 12.1% | +1.0 pts | Form 8-K (abbv-20221231xexhibit991.htm, filed 2023-02-09) ↗ |
| FY2021 | Dec 31, 2021 | 11.1% | +47.1 pts | Form 10-K (filed 2024-02-20) ↗ |
| FY2020 | Dec 31, 2020 | -36.0% | -42.5 pts | Form 10-K (filed 2023-02-17) ↗ |
| FY2019 | Dec 31, 2019 | 6.5% | +15.9 pts | Form 10-K (filed 2022-02-18) ↗ |
| FY2018 | Dec 31, 2018 | -9.4% | -40.7 pts | Form 10-K (filed 2021-02-19) ↗ |
| FY2017 | Dec 31, 2017 | 31.3% | +6.8 pts | Form 10-K (filed 2020-02-21) ↗ |
| FY2016 | Dec 31, 2016 | 24.5% | +1.9 pts | Form 10-K (filed 2019-02-27) ↗ |
| FY2015 | Dec 31, 2015 | 22.6% | – | Form 10-K (filed 2018-02-16) ↗ |
Cite this data
StockData. (2026). AbbVie GAAP Effective Tax Rate (%) (%), annual FY2015–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/nongaap_gaap_tax_rate
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.